Mauna Kea Technologies SAS Asset Resilience Ratio
Mauna Kea Technologies SAS asset resilience ratio. Mauna Kea Technologies SAS (ALMKT) has an Asset Resilience Ratio of 5.24% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Mauna Kea Technologies SAS (ALMKT) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Mauna Kea Technologies SAS (2011–2024)
Asset resilience ratio of Mauna Kea Technologies SAS from 2011 to 2024. This chart shows how Mauna Kea Technologies SAS's Asset Resilience Ratio has changed over time. Read debt load of Mauna Kea Technologies SAS for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Mauna Kea Technologies SAS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Mauna Kea Technologies SAS's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €663.00K | 5.24% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €663.00K | 5.24% |
Asset Resilience Insights
- Limited Liquidity: Mauna Kea Technologies SAS maintains only 5.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Mauna Kea Technologies SAS Industry Peers by Asset Resilience Ratio
Compare Mauna Kea Technologies SAS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
Mauna Kea Technologies SAS Asset Resilience Ratio by Year (2011–2024)
Mauna Kea Technologies SAS asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Mauna Kea Technologies SAS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 12.42% | €2.02 Million ≈ $2.36 Million |
€16.25 Million ≈ $18.99 Million |
+12.26pp |
| 2023-12-31 | 0.16% | €36.00K ≈ $42.09K |
€22.94 Million ≈ $26.82 Million |
+0.11pp |
| 2022-12-31 | 0.05% | €9.00K ≈ $10.52K |
€19.79 Million ≈ $23.14 Million |
-0.07pp |
| 2021-12-31 | 0.12% | €29.00K ≈ $33.90K |
€24.75 Million ≈ $28.94 Million |
-0.16pp |
| 2020-12-31 | 0.28% | €58.00K ≈ $67.81K |
€20.61 Million ≈ $24.09 Million |
+0.03pp |
| 2019-12-31 | 0.25% | €59.00K ≈ $68.98K |
€23.62 Million ≈ $27.62 Million |
-0.07pp |
| 2018-12-31 | 0.32% | €64.00K ≈ $74.82K |
€19.76 Million ≈ $23.10 Million |
-0.13pp |
| 2017-12-31 | 0.45% | €125.00K ≈ $146.14K |
€27.75 Million ≈ $32.44 Million |
-0.02pp |
| 2016-12-31 | 0.47% | €94.00K ≈ $109.90K |
€19.97 Million ≈ $23.35 Million |
+0.18pp |
| 2015-12-31 | 0.29% | €65.00K ≈ $75.99K |
€22.50 Million ≈ $26.31 Million |
-0.18pp |
| 2014-12-31 | 0.46% | €128.00K ≈ $149.65K |
€27.54 Million ≈ $32.19 Million |
-0.06pp |
| 2013-12-31 | 0.52% | €207.00K ≈ $242.00K |
€39.54 Million ≈ $46.23 Million |
+0.09pp |
| 2012-12-31 | 0.43% | €211.00K ≈ $246.68K |
€49.06 Million ≈ $57.35 Million |
-1.13pp |
| 2011-12-31 | 1.56% | €943.00K ≈ $1.10 Million |
€60.30 Million ≈ $70.50 Million |
-- |
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more